Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 22 | 23 | +1 |
| Shares | 1.19M | 1.28M | +96.3K (+8.1%) |
| Value | $1.35M | $3.85M | +$2.49M (+184.7%) |
New holders (4)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 40,300 | $120.9K | 0.00% |
| Qube Research & Technologies Ltd | 2,191 | $6.57K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 136 | $408 | 0.00% |
| Team Financial Group, LLC | 71 | $213 | 0.00% |
Sold out (3)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| HRT Financial LP | 19,742 | $22.0K |
| JPMorgan Chase & Co | 148 | $169 |
| Simplex Trading, LLC | 103 | $0 |